Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell forðaplástur 14 mg/24 klst.
haleon denmark aps - nicotinum - forðaplástur - 14 mg/24 klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell forðaplástur 21 mg/24 klst.
haleon denmark aps - nicotinum - forðaplástur - 21 mg/24 klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell forðaplástur 7 mg/24 klst.
haleon denmark aps - nicotinum - forðaplástur - 7 mg/24 klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell spearmint lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint munnsogstafla 2 mg
haleon denmark aps - nicotinum bítartrat - munnsogstafla - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint munnsogstafla 1 mg
haleon denmark aps - nicotinum bítartrat - munnsogstafla - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint lyfjatyggigúmmí 2 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell lakrids lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg